DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines

DOPS Adjuvant Confers Enhanced Protection against Malaria for VLP-TRAP Based Vaccines

Vaccination remains the most effective and essential prophylactic tool against infectious diseases. Enormous efforts have been made to develop effective vaccines against malaria but successes remain so far limited. Novel adjuvants may offer a significant advantage in the development of malaria vacci...

Full description

Bibliographic Details
Main Authors: Gustavo Cabral-Miranda, Ahmed M. Salman, Mona O. Mohsen, Federico L. Storni, Elisa S. Roesti, Murray A. Skinner, Matthew D. Heath, Matthias F. Kramer, Shahid M. Khan, Chris J. Janse, Adrian V. S. Hill, Martin F. Bachmann
Format: Article
Language:English
Published: MDPI AG 2018-11-01
Series:Diseases
Subjects:
vaccine
adjuvants
<i>Plasmodium falciparum</i>
malaria
virus like particle (VLP)
dioleoyl phosphatidylserine (DOPS)
Online Access:https://www.mdpi.com/2079-9721/6/4/107

Internet

https://www.mdpi.com/2079-9721/6/4/107

Similar Items